Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated:  12/31/1969
Saint Francis Hospital
mi
from
Roslyn, NY
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated: 12/31/1969
Saint Francis Hospital
mi
from
Roslyn, NY
Click here to add this to my saved trials
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated:  12/31/1969
Sanford Medical Center
mi
from
Fargo, ND
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated: 12/31/1969
Sanford Medical Center
mi
from
Fargo, ND
Click here to add this to my saved trials
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated:  12/31/1969
University Hospitals Elyria Medical Center
mi
from
Elyria, OH
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated: 12/31/1969
University Hospitals Elyria Medical Center
mi
from
Elyria, OH
Click here to add this to my saved trials
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated:  12/31/1969
AnMed Health Medical Center
mi
from
Anderson, SC
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated: 12/31/1969
AnMed Health Medical Center
mi
from
Anderson, SC
Click here to add this to my saved trials
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated:  12/31/1969
Centennial Medical Center
mi
from
Nashville, TN
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated: 12/31/1969
Centennial Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated:  12/31/1969
Dallas VA Medical Center
mi
from
Dallas, TX
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated: 12/31/1969
Dallas VA Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated:  12/31/1969
Lankenau Medical Center
mi
from
Wynnewood, PA
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated: 12/31/1969
Lankenau Medical Center
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus
Pharmacodynamic Effects of Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus: The Optimizing Anti-Platelet Therapy In Diabetes MellitUS (OPTIMUS)-5 Study
Status: Enrolling
Updated:  12/31/1969
University of Florida
mi
from
Jacksonville, FL
Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus
Pharmacodynamic Effects of Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus: The Optimizing Anti-Platelet Therapy In Diabetes MellitUS (OPTIMUS)-5 Study
Status: Enrolling
Updated: 12/31/1969
University of Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
CPR Education Via a Mobile Application Compared to VSI Kit
CPR Education for Families of Cardiac Patients Before Hospital Discharge
Status: Enrolling
Updated:  12/31/1969
Cooper University Hospital
mi
from
Camden, NJ
CPR Education Via a Mobile Application Compared to VSI Kit
CPR Education for Families of Cardiac Patients Before Hospital Discharge
Status: Enrolling
Updated: 12/31/1969
Cooper University Hospital
mi
from
Camden, NJ
Click here to add this to my saved trials
CPR Education Via a Mobile Application Compared to VSI Kit
CPR Education for Families of Cardiac Patients Before Hospital Discharge
Status: Enrolling
Updated:  12/31/1969
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
CPR Education Via a Mobile Application Compared to VSI Kit
CPR Education for Families of Cardiac Patients Before Hospital Discharge
Status: Enrolling
Updated: 12/31/1969
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
CPR Education Via a Mobile Application Compared to VSI Kit
CPR Education for Families of Cardiac Patients Before Hospital Discharge
Status: Enrolling
Updated:  12/31/1969
Penn Presbyterian Medical Center
mi
from
Philadelphia, PA
CPR Education Via a Mobile Application Compared to VSI Kit
CPR Education for Families of Cardiac Patients Before Hospital Discharge
Status: Enrolling
Updated: 12/31/1969
Penn Presbyterian Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
CPR Education Via a Mobile Application Compared to VSI Kit
CPR Education for Families of Cardiac Patients Before Hospital Discharge
Status: Enrolling
Updated:  12/31/1969
Pennsylvania Hospital
mi
from
Philadelphia, PA
CPR Education Via a Mobile Application Compared to VSI Kit
CPR Education for Families of Cardiac Patients Before Hospital Discharge
Status: Enrolling
Updated: 12/31/1969
Pennsylvania Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
CPR Education Via a Mobile Application Compared to VSI Kit
CPR Education for Families of Cardiac Patients Before Hospital Discharge
Status: Enrolling
Updated:  12/31/1969
Albert Einstein Medical Center
mi
from
Philadelphia, PA
CPR Education Via a Mobile Application Compared to VSI Kit
CPR Education for Families of Cardiac Patients Before Hospital Discharge
Status: Enrolling
Updated: 12/31/1969
Albert Einstein Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
CPR Education Via a Mobile Application Compared to VSI Kit
CPR Education for Families of Cardiac Patients Before Hospital Discharge
Status: Enrolling
Updated:  12/31/1969
Crozer-Keystone Health System
mi
from
Upland, PA
CPR Education Via a Mobile Application Compared to VSI Kit
CPR Education for Families of Cardiac Patients Before Hospital Discharge
Status: Enrolling
Updated: 12/31/1969
Crozer-Keystone Health System
mi
from
Upland, PA
Click here to add this to my saved trials
CPR Education Via a Mobile Application Compared to VSI Kit
CPR Education for Families of Cardiac Patients Before Hospital Discharge
Status: Enrolling
Updated:  12/31/1969
The Chester County Hospital and Health System
mi
from
West Chester, PA
CPR Education Via a Mobile Application Compared to VSI Kit
CPR Education for Families of Cardiac Patients Before Hospital Discharge
Status: Enrolling
Updated: 12/31/1969
The Chester County Hospital and Health System
mi
from
West Chester, PA
Click here to add this to my saved trials
Phase I Safety and Feasibility Study of Intracoronary Delivery of Autologous Bone Marrow Derived Mononuclear Cells
Phase I Safety and Feasibility Study of Intracoronary Delivery of Autologous Bone Marrow Derived Mononuclear Cells for Systemic, Single Right Ventricular Failure Due to Congenital Heart Disease
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Phase I Safety and Feasibility Study of Intracoronary Delivery of Autologous Bone Marrow Derived Mononuclear Cells
Phase I Safety and Feasibility Study of Intracoronary Delivery of Autologous Bone Marrow Derived Mononuclear Cells for Systemic, Single Right Ventricular Failure Due to Congenital Heart Disease
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Antiplatelet Therapy in HIV
Antiplatelet Therapy in HIV - Antiplatelet and Immune Modulating Effects of Aspirin or Clopidogrel in Subjects With HIV
Status: Enrolling
Updated:  12/31/1969
Bellevue Hospital
mi
from
New York, NY
Antiplatelet Therapy in HIV
Antiplatelet Therapy in HIV - Antiplatelet and Immune Modulating Effects of Aspirin or Clopidogrel in Subjects With HIV
Status: Enrolling
Updated: 12/31/1969
Bellevue Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Antiplatelet Therapy in HIV
Antiplatelet Therapy in HIV - Antiplatelet and Immune Modulating Effects of Aspirin or Clopidogrel in Subjects With HIV
Status: Enrolling
Updated:  12/31/1969
NYU Langone Medical Center
mi
from
New York, NY
Antiplatelet Therapy in HIV
Antiplatelet Therapy in HIV - Antiplatelet and Immune Modulating Effects of Aspirin or Clopidogrel in Subjects With HIV
Status: Enrolling
Updated: 12/31/1969
NYU Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk
Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk
Status: Enrolling
Updated:  12/31/1969
San Francisco General Hospital
mi
from
San Francisco, CA
Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk
Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk
Status: Enrolling
Updated: 12/31/1969
San Francisco General Hospital
mi
from
San Francisco, CA
Click here to add this to my saved trials
Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk
Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk
Status: Enrolling
Updated:  12/31/1969
Quest Clinical Research
mi
from
San Francisco, CA
Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk
Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk
Status: Enrolling
Updated: 12/31/1969
Quest Clinical Research
mi
from
San Francisco, CA
Click here to add this to my saved trials
Men Together Making a Difference: Health Promotion for Black Men
Health Promotion for HIV Positives: A Randomized Trial With HIV Positive Black Men
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Men Together Making a Difference: Health Promotion for Black Men
Health Promotion for HIV Positives: A Randomized Trial With HIV Positive Black Men
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-141
A Prospective Multicenter Phase III Clinical Evaluation of the Safety and Efficacy of Lumason™/SonoVue® in Subjects Undergoing Pharmacologic Stress Echocardiography With Dobutamine for the Diagnosis of Coronary Artery Disease
Status: Enrolling
Updated:  12/31/1969
St. Luke's Hospital of Kansas City
mi
from
Kansas City, MO
Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-141
A Prospective Multicenter Phase III Clinical Evaluation of the Safety and Efficacy of Lumason™/SonoVue® in Subjects Undergoing Pharmacologic Stress Echocardiography With Dobutamine for the Diagnosis of Coronary Artery Disease
Status: Enrolling
Updated: 12/31/1969
St. Luke's Hospital of Kansas City
mi
from
Kansas City, MO
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial - Inflammation Imaging Study
Cardiovascular Inflammation Reduction Trial (CIRT) - Inflammation Imaging Study
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Cardiovascular Inflammation Reduction Trial - Inflammation Imaging Study
Cardiovascular Inflammation Reduction Trial (CIRT) - Inflammation Imaging Study
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial - Inflammation Imaging Study
Cardiovascular Inflammation Reduction Trial (CIRT) - Inflammation Imaging Study
Status: Enrolling
Updated:  12/31/1969
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Cardiovascular Inflammation Reduction Trial - Inflammation Imaging Study
Cardiovascular Inflammation Reduction Trial (CIRT) - Inflammation Imaging Study
Status: Enrolling
Updated: 12/31/1969
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial - Inflammation Imaging Study
Cardiovascular Inflammation Reduction Trial (CIRT) - Inflammation Imaging Study
Status: Enrolling
Updated:  12/31/1969
St. Michael's Hospital
mi
from
Toronto,
Cardiovascular Inflammation Reduction Trial - Inflammation Imaging Study
Cardiovascular Inflammation Reduction Trial (CIRT) - Inflammation Imaging Study
Status: Enrolling
Updated: 12/31/1969
St. Michael's Hospital
mi
from
Toronto,
Click here to add this to my saved trials
Rhode Island Diastolic Dysfunction - Heart Failure
Rhode Island Diastolic Dysfunction - Heart Failure
Status: Enrolling
Updated:  12/31/1969
Providence VAMC
mi
from
Providence, RI
Rhode Island Diastolic Dysfunction - Heart Failure
Rhode Island Diastolic Dysfunction - Heart Failure
Status: Enrolling
Updated: 12/31/1969
Providence VAMC
mi
from
Providence, RI
Click here to add this to my saved trials
Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142
A Prospective Multicenter Phase III Clinical Evaluation of the Safety and Efficacy of Lumason™/SonoVue® in Subjects Undergoing Pharmacologic Stress Echocardiography With Dobutamine for the Diagnosis of Coronary Artery Disease
Status: Enrolling
Updated:  12/31/1969
Alfieri Cardiology
mi
from
Wilmington, DE
Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142
A Prospective Multicenter Phase III Clinical Evaluation of the Safety and Efficacy of Lumason™/SonoVue® in Subjects Undergoing Pharmacologic Stress Echocardiography With Dobutamine for the Diagnosis of Coronary Artery Disease
Status: Enrolling
Updated: 12/31/1969
Alfieri Cardiology
mi
from
Wilmington, DE
Click here to add this to my saved trials
Healthy Hearts in the Heartland
Midwest Small Practice Care Transformation Research Alliance (MSPCTRA)
Status: Enrolling
Updated:  12/31/1969
Northwestern University
mi
from
Chicago, IL
Healthy Hearts in the Heartland
Midwest Small Practice Care Transformation Research Alliance (MSPCTRA)
Status: Enrolling
Updated: 12/31/1969
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Healthy Hearts in the Heartland
Midwest Small Practice Care Transformation Research Alliance (MSPCTRA)
Status: Enrolling
Updated:  12/31/1969
Northern Illinois University (NIU)
mi
from
DeKalb, IL
Healthy Hearts in the Heartland
Midwest Small Practice Care Transformation Research Alliance (MSPCTRA)
Status: Enrolling
Updated: 12/31/1969
Northern Illinois University (NIU)
mi
from
DeKalb, IL
Click here to add this to my saved trials
Healthy Hearts in the Heartland
Midwest Small Practice Care Transformation Research Alliance (MSPCTRA)
Status: Enrolling
Updated:  12/31/1969
Telligen
mi
from
Oak Brook, IL
Healthy Hearts in the Heartland
Midwest Small Practice Care Transformation Research Alliance (MSPCTRA)
Status: Enrolling
Updated: 12/31/1969
Telligen
mi
from
Oak Brook, IL
Click here to add this to my saved trials
Healthy Hearts in the Heartland
Midwest Small Practice Care Transformation Research Alliance (MSPCTRA)
Status: Enrolling
Updated:  12/31/1969
Purdue University
mi
from
West Lafayette, IN
Healthy Hearts in the Heartland
Midwest Small Practice Care Transformation Research Alliance (MSPCTRA)
Status: Enrolling
Updated: 12/31/1969
Purdue University
mi
from
West Lafayette, IN
Click here to add this to my saved trials
Healthy Hearts in the Heartland
Midwest Small Practice Care Transformation Research Alliance (MSPCTRA)
Status: Enrolling
Updated:  12/31/1969
MetaStar
mi
from
Madison, WI
Healthy Hearts in the Heartland
Midwest Small Practice Care Transformation Research Alliance (MSPCTRA)
Status: Enrolling
Updated: 12/31/1969
MetaStar
mi
from
Madison, WI
Click here to add this to my saved trials
The Neu-Prem Trial: Neuromonitoring of Preterm Newborn Brain During Birth Resuscitation
The Neu-Prem Trial: Neuromonitoring of Preterm Newborn Brain During Birth Resuscitation
Status: Enrolling
Updated:  12/31/1969
Sharp Mary Birch Hospital for Women and Newborns
mi
from
San Diego, CA
The Neu-Prem Trial: Neuromonitoring of Preterm Newborn Brain During Birth Resuscitation
The Neu-Prem Trial: Neuromonitoring of Preterm Newborn Brain During Birth Resuscitation
Status: Enrolling
Updated: 12/31/1969
Sharp Mary Birch Hospital for Women and Newborns
mi
from
San Diego, CA
Click here to add this to my saved trials
Changes in Cerebral Oxygenation During Laparoscopy in Patients With Single Ventricle Anatomy
Status: Enrolling
Updated:  12/31/1969
Nationwide Children's Hospital
mi
from
Columbus, OH
Changes in Cerebral Oxygenation During Laparoscopy in Patients With Single Ventricle Anatomy
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated:  12/31/1969
Good Samaritan Hospital Regional Medical Center
mi
from
San Jose, CA
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated: 12/31/1969
Good Samaritan Hospital Regional Medical Center
mi
from
San Jose, CA
Click here to add this to my saved trials
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated:  12/31/1969
Riverside Radiology and Interventional Associates
mi
from
Columbus, OH
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated: 12/31/1969
Riverside Radiology and Interventional Associates
mi
from
Columbus, OH
Click here to add this to my saved trials
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated:  12/31/1969
St Vincent Mercy Hospital
mi
from
Toledo, OH
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated: 12/31/1969
St Vincent Mercy Hospital
mi
from
Toledo, OH
Click here to add this to my saved trials
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated:  12/31/1969
OHSU Stroke Center
mi
from
Portland, OR
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated: 12/31/1969
OHSU Stroke Center
mi
from
Portland, OR
Click here to add this to my saved trials
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated:  12/31/1969
UPMC Stroke Center
mi
from
Pittsburgh, PA
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated: 12/31/1969
UPMC Stroke Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated:  12/31/1969
Tennessee Interventional and Imaging Associates
mi
from
Chattanooga, TN
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated: 12/31/1969
Tennessee Interventional and Imaging Associates
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated:  12/31/1969
AZ Groeninge
mi
from
Kortrijk,
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated: 12/31/1969
AZ Groeninge
mi
from
Kortrijk,
Click here to add this to my saved trials
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated:  12/31/1969
UCLA
mi
from
Los Angeles, CA
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated: 12/31/1969
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated:  12/31/1969
University of Miami and Jackson Memorial Hospital
mi
from
Miami, FL
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated: 12/31/1969
University of Miami and Jackson Memorial Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated:  12/31/1969
Emory University School of Medicine
mi
from
Atlanta, GA
Analysis of Revascularization in Ischemic Stroke With EmboTrap
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Status: Enrolling
Updated: 12/31/1969
Emory University School of Medicine
mi
from
Atlanta, GA
Click here to add this to my saved trials
Bococizumab HIV Evaluation (B-HIVE) Study
Bococizumab HIV Evaluation (B-HIVE) Study: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of Bococizumab, a PCSK9 Inhibitor, in HIV-Infected Subjects
Status: Enrolling
Updated:  12/31/1969
San Francisco General Hospital
mi
from
San Francisco, CA
Bococizumab HIV Evaluation (B-HIVE) Study
Bococizumab HIV Evaluation (B-HIVE) Study: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of Bococizumab, a PCSK9 Inhibitor, in HIV-Infected Subjects
Status: Enrolling
Updated: 12/31/1969
San Francisco General Hospital
mi
from
San Francisco, CA
Click here to add this to my saved trials
Bococizumab HIV Evaluation (B-HIVE) Study
Bococizumab HIV Evaluation (B-HIVE) Study: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of Bococizumab, a PCSK9 Inhibitor, in HIV-Infected Subjects
Status: Enrolling
Updated:  12/31/1969
Quest Clinical Research
mi
from
San Francisco, CA
Bococizumab HIV Evaluation (B-HIVE) Study
Bococizumab HIV Evaluation (B-HIVE) Study: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of Bococizumab, a PCSK9 Inhibitor, in HIV-Infected Subjects
Status: Enrolling
Updated: 12/31/1969
Quest Clinical Research
mi
from
San Francisco, CA
Click here to add this to my saved trials
Bococizumab HIV Evaluation (B-HIVE) Study
Bococizumab HIV Evaluation (B-HIVE) Study: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of Bococizumab, a PCSK9 Inhibitor, in HIV-Infected Subjects
Status: Enrolling
Updated:  12/31/1969
San Francisco Veteran's Affair Medical Center
mi
from
San Francisco, CA
Bococizumab HIV Evaluation (B-HIVE) Study
Bococizumab HIV Evaluation (B-HIVE) Study: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of Bococizumab, a PCSK9 Inhibitor, in HIV-Infected Subjects
Status: Enrolling
Updated: 12/31/1969
San Francisco Veteran's Affair Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
The KaHOLO Project: Preventing Cardiovascular Disease in Native Hawaiians
The KaHOLO Project: Preventing Cardiovascular Disease in Native Hawaiians
Status: Enrolling
Updated:  12/31/1969
University of Hawaii, John A Burns School of Medicine, Department of Native Hawaiian Health
mi
from
Honolulu, HI
The KaHOLO Project: Preventing Cardiovascular Disease in Native Hawaiians
The KaHOLO Project: Preventing Cardiovascular Disease in Native Hawaiians
Status: Enrolling
Updated: 12/31/1969
University of Hawaii, John A Burns School of Medicine, Department of Native Hawaiian Health
mi
from
Honolulu, HI
Click here to add this to my saved trials
Inflammatory Pathogenesis of Coronary Atherosclerosis in HIV
Inflammatory Pathogenesis of Coronary Atherosclerosis in HIV
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Inflammatory Pathogenesis of Coronary Atherosclerosis in HIV
Inflammatory Pathogenesis of Coronary Atherosclerosis in HIV
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials